Arthritis Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027

Published on : Dec-2019 | List of Tables : 30 | List of Figures : 89 | No. of Pages : 170 | Report Code : FACT4355MR | Format : ppt pdf Excel Word

Biologics Emerging as Panacea in Arthritis Therapeutics Market

Global health data suggests that, the populace in North America and Europe are more conscious regarding arthritis, and actively partake in diagnosis than those residing in developing countries. Sensing the success rate of arthritis therapeutics, manufacturers are allocating high budgets to fuel their research & development activities, which ensures the future availability of blockbuster drugs.

The recent time is, however, witnessing a shifting paradigm of patients’ reliance from pharmaceutical products towards biologics, as biologic therapies are reported to bring dramatic improvements in patients’ quality of life. Furthermore, there are several biologic products in phase III clinical trials, which is indicative of strong commercial prospects for manufacturers in the arthritis therapeutics market.

Weighing the impact of key influencers, a recent report published by Fact.MR infers that, the arthritis therapeutics market is estimated to grow 1.5X during the forecast period (2020 - 2027).

key segments in arthritis therapeutics market

For detailed insights on market taxonomy, request a sample copy of the report here.

Parenteral Qualifies as Default Route of Administration

According to the Fact.MR study, preference for the parenteral route of administration will be 83% more than the topical and oral routes combined in 2020, on account of the high precision of dosage offered by this route, which leads to better patient outcomes. Cost and recovery time, in turn, are turning out to be key determiners in the selection of route of administration. Following this, increased availability of biosimilar products at competitive rates through parenteral routes is projected to retain high preference for the injection of drugs during the forecast period.

On a relative note, patients’ proclivity for oral arthritis therapeutics is likely to remain moderate, as this route is preferred in cases wherein patients are required to follow a long-term course of medication. Additionally, the introduction of topical NSAIDs for the treatment of joint pains will offer low-to-moderate stimulus to the topical route of administration in the arthritis therapeutics market during the forecast period.

Steep Rise in Drug Prices to Take a Toll on Health of Arthritis Therapeutics Market

Advanced antibody therapeutics have been outperforming the sales of disease-modifying antirheumatic drugs (DMARD) in recent times, on account of their relatively high efficiency. However, better outcomes offered by these drugs comes at a price, a steep one indeed, which accommodates a range of US$ 1,000 to US$ 3,000 per month.

The price of the popular drug used for treatment of arthritis - Humira - increased by 100% from US$ 19,000 a year in 2012 to US$ 38,000 a year in 2018, as per data presented by SSR Health. This price rise is not limited to only Humira. Enbrel saw an 80% hike in its price since 2013, as reported by the Alliance of Community Health Plans. Given the long-term recommendation of these drugs to control arthritis, a perpetual increase in prices could shake the monthly budgets of patients, and, is hence, diverting their attention towards complementary and alternative therapies.

How can Manufacturers Offset Challenges Associated with High Cost of Drugs?

High penetration of smartphones in parallel to low-cost of operation of distribution network is promising the growth of online pharmacies as a key distribution channel. In the arthritis therapeutics market, where high cost concerns have been impeding sales prospects for players, targeting sales through online pharmacies can help offset the challenge through heavy deals and discounts offered by these channels. In 2020, online pharmacies are projected to drive sales tantamount to a value of US$ 3.5 Bn, and the trend of online shopping driven by convenience will strengthen sales in future.

Currently, retail pharmacies account for 79% of total sales in the arthritis therapeutics market, as large chains and strong distribution network coupled with 24X7 accessibility is gaining prominence to this distribution channel. It is recommended for players in the arthritis therapeutics market to increase distribution-oriented partnerships with key retail partners to amplify their sales.

global arthritis therapeutics market opportunity assessment by drug class

For detailed regional analysis, request a sample copy of the report here.

North America’s Lead Fuelled by High Availability of Drugs

The arthritis therapeutics market is more concentrated in developed regions such as North America and Europe as compared to other parts of the world. Rigorous research & development initiatives undertaken by players concentrated in these regions are projected to diversify portfolios, strengthen the pipeline of drugs, and, in turn, boost the availability of drugs. Recent addition of biologic and biosimilar in the arthritis therapeutics list, on the backdrop of patent expiration of blockbuster drugs, is witnessed in these regions. In developing regions, increasing investments directed towards bringing progressive improvements in the healthcare industry are projected to promise strong growth for the arthritis therapeutics market in Asia Pacific. In developed countries of Asia Pacific, such as Japan, New Zealand, and Australia, the adoption of biologic drugs is anticipated to remain high during the forecast period.

Request research methodology of this report.

Arthritis Therapeutics Market - Scope of the Study

Fact.MR, in its exclusive research report on the arthritis therapeutics market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the arthritis therapeutics market during the forecast period (2020 - 2027). With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the arthritis therapeutics market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the arthritis therapeutics market. The study also recalibrates the impact of each of these dynamics to estimate the size of the arthritis therapeutics market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that hold potential to influence the growth of the arthritis therapeutics market during the forecast period.

The global study offers crucial information about global, regional, and local players operating in the arthritis therapeutics market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players, the study also aims at equipping stakeholders with the best of information regarding winning strategies, recent developments, and financials.

Arthritis Therapeutics Market - Assessment of Key Segments

With an aim to offer granular level insights into the arthritis therapeutics market, authors of the report have segmented the landscape on the basis of type, drug class, route of administration, distribution channel, and region. This global research report also offers information regarding the incremental opportunity available in the arthritis therapeutics market during the forecast period. Key segments of the arthritis therapeutics market include:

Type

Drug Class

Route of Administration

Distribution Channel

Region

Rheumatoid Arthritis

TNF Inhibitors

Oral

Hospital Pharmacies

North America

Osteoarthritis

Interleukin Inhibitors

Parenteral

Retail Pharmacies

Europe

Arthritis

NSAIDS

Topical

Online Pharmacies

Asia Pacific

Gout

Corticosteroids

 

 

Latin America

Others

Xanthine Oxidase Inhibitors

 

 

Middle East & Africa

 

Others

 

 

 

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the global arthritis therapeutics market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the arthritis therapeutics market.

Key players profiled in this comprehensive study on the arthritis therapeutics market include Sanofi, Novartis AG, F.Hoffmann-La Roche Ltd, Eli Lily and Company, Janssen Global Services, LLC, Amgen, Inc., AbbVie, Inc., Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, and Merck & Co., Inc.

Arthritis Therapeutics Market - Research Methodology

The research undertaken by seasoned analysts at Fact.MR consists of a systematic approach. A combination of the bottom-up and top-down approach is leveraged to estimate the size of the arthritis therapeutics market. Besides this, primary and secondary researches are carried out through credible sources to gain crucial insights into the arthritis therapeutics market. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors.

Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the arthritis therapeutics market. In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as company annual reports, investor presentations, and SEC-filings were studied.

Besides this, governmental and public portals, such as World Health Organization (WHO), OECD, FDA, Centres of Disease Control and Prevention (CDC), the Centres for Medicare & Medicaid Services, MoHFW, Government of India, Dermatology News, Arthritis Foundation, National Psoriasis Foundation, Arthritis Foundation, Psoriasis Association, European Societies of Dermatology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Centre for Complementary and Integrative Health were referred to, in order to gain crucial information regarding key players in the arthritis therapeutics market. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Arthritis Therapeutics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Arthritis Therapeutics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key product/brand Analysis

    5.2. Pipeline Analysis

    5.3. Disease Prevalence & Incidence Rate globally with key countries

    5.4. Regulatory Scenario by Region/globally

6. Global Arthritis Therapeutics Market Analysis and Forecast, By Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

        6.3.1. Rheumatoid Arthritis

        6.3.2. Osteoarthritis

        6.3.3. Psoriatic Arthritis

        6.3.4. Gout

        6.3.5. Others

    6.4. Market Attractiveness By Type

7. Global Arthritis Therapeutics Market Analysis and Forecast, By Drug Class 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        7.3.1. TNF Inhibitors

        7.3.2. Interleukin Inhibitors

        7.3.3. NSAIDs

        7.3.4. Corticosteroids

        7.3.5. Xanthine Oxidase Inhibitors

        7.3.6. Others

    7.4. Market Attractiveness By Drug Class 

8. Global Arthritis Therapeutics Market Analysis and Forecast, By Route of Administration 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        8.3.1. Oral

        8.3.2. Parenteral

        8.3.3. Topical 

    8.4. Market Attractiveness By Route of Administration 

9. Global Arthritis Therapeutics Market Analysis and Forecast, By Distribution Channel 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. Market Attractiveness By Distribution Channel

10. Global Arthritis Therapeutics Market Analysis and Forecast, By Region 

    10.1. Key Findings

    10.2. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Region

        10.2.1. North America

        10.2.2. Europe 

        10.2.3. Asia Pacific

        10.2.4. Latin America 

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness By Country/Sub-region /Region

11. North America Arthritis Therapeutics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        11.2.1. Rheumatoid Arthritis

        11.2.2. Osteoarthritis

        11.2.3. Psoriatic Arthritis

        11.2.4. Gout

        11.2.5. Others

    11.3. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        11.3.1. TNF Inhibitors

        11.3.2. Interleukin Inhibitors

        11.3.3. NSAIDs

        11.3.4. Corticosteroids

        11.3.5. Xanthine Oxidase Inhibitors

        11.3.6. Others

    11.4. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        11.4.1. Oral

        11.4.2. Parenteral

        11.4.3. Topical 

    11.5. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Drug Class

        11.7.3. By Route of Administration

        11.7.4. By Distribution Channel

        11.7.5. By Country/Sub-region

12. Europe Arthritis Therapeutics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        12.2.1. Rheumatoid Arthritis

        12.2.2. Osteoarthritis

        12.2.3. Psoriatic Arthritis

        12.2.4. Gout

        12.2.5. Others

    12.3. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        12.3.1. TNF Inhibitors

        12.3.2. Interleukin Inhibitors

        12.3.3. NSAIDs

        12.3.4. Corticosteroids

        12.3.5. Xanthine Oxidase Inhibitors

        12.3.6. Others

    12.4. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        12.4.1. Oral

        12.4.2. Parenteral

        12.4.3. Topical 

    12.5. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Drug Class

        12.7.3. By Route of Administration

        12.7.4. By Distribution Channel

        12.7.5. By Country/Sub-region

13. Asia Pacific Arthritis Therapeutics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        13.2.1. Rheumatoid Arthritis

        13.2.2. Osteoarthritis

        13.2.3. Psoriatic Arthritis

        13.2.4. Gout

        13.2.5. Others

    13.3. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        13.3.1. TNF Inhibitors

        13.3.2. Interleukin Inhibitors

        13.3.3. NSAIDs

        13.3.4. Corticosteroids

        13.3.5. Xanthine Oxidase Inhibitors

        13.3.6. Others

    13.4. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        13.4.1. Oral

        13.4.2. Parenteral

        13.4.3. Topical 

    13.5. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Online Pharmacies

    13.6. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Drug Class

        13.7.3. By Route of Administration

        13.7.4. By Distribution Channel

        13.7.5. By Country/Sub-region

14. Latin America Arthritis Therapeutics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        14.2.1. Rheumatoid Arthritis

        14.2.2. Osteoarthritis

        14.2.3. Psoriatic Arthritis

        14.2.4. Gout

        14.2.5. Others

    14.3. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        14.3.1. TNF Inhibitors

        14.3.2. Interleukin Inhibitors

        14.3.3. NSAIDs

        14.3.4. Corticosteroids

        14.3.5. Xanthine Oxidase Inhibitors

        14.3.6. Others

    14.4. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        14.4.1. Oral

        14.4.2. Parenteral

        14.4.3. Topical 

    14.5. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Drug Class

        14.7.3. By Route of Administration

        14.7.4. By Distribution Channel

        14.7.5. By Country/Sub-region 

15. Middle East & Africa Arthritis Therapeutics Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        15.2.1. Rheumatoid Arthritis

        15.2.2. Osteoarthritis

        15.2.3. Psoriatic Arthritis

        15.2.4. Gout

        15.2.5. Others

    15.3. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        15.3.1. TNF Inhibitors

        15.3.2. Interleukin Inhibitors

        15.3.3. NSAIDs

        15.3.4. Corticosteroids

        15.3.5. Xanthine Oxidase Inhibitors

        15.3.6. Others

    15.4. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        15.4.1. Oral

        15.4.2. Parenteral

        15.4.3. Topical 

    15.5. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Online Pharmacies

    15.6. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By Drug Class

        15.7.3. By Route of Administration

        15.7.4. By Distribution Channel

        15.7.5. By Country/Sub-region 

16. Competition Landscape

    16.1. Market Share Analysis By Company (2018)

    16.2. Company Profiles

        16.2.1. Novartis AG

        16.2.2. Eli Lilly and Company

        16.2.3. Amgen, Inc.

        16.2.4. Merck & Co., Inc.

        16.2.5. Bristol-Myers Squibb Company

        16.2.6. Pfizer, Inc. 

        16.2.7. AbbVie, Inc.

        16.2.8. Janssen Global Services, LLC (Johnson & Johnson)

        16.2.9. F. Hoffmann-La Roche Ltd

        16.2.10. Sanofi

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Arthritis Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027